These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of MDR1 1236C > T-2677G > T-3435C > T polymorphisms on the intracellular accumulation of tacrolimus, cyclosporine A, sirolimus and everolimus. Wang R, Sun X, Deng YS, Qiu XW. Xenobiotica; 2019 Nov; 49(11):1373-1378. PubMed ID: 30587068 [Abstract] [Full Text] [Related]
3. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines. van der Sandt IC, Blom-Roosemalen MC, de Boer AG, Breimer DD. Eur J Pharm Sci; 2000 Sep; 11(3):207-14. PubMed ID: 11042226 [Abstract] [Full Text] [Related]
5. Interaction of docetaxel ("Taxotere") with human P-glycoprotein. Shirakawa K, Takara K, Tanigawara Y, Aoyama N, Kasuga M, Komada F, Sakaeda T, Okumura K. Jpn J Cancer Res; 1999 Dec; 90(12):1380-6. PubMed ID: 10665657 [Abstract] [Full Text] [Related]
7. Human P-glycoprotein transports cyclosporin A and FK506. Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T. J Biol Chem; 1993 Mar 25; 268(9):6077-80. PubMed ID: 7681059 [Abstract] [Full Text] [Related]
9. (R)- and (S)-[11C]verapamil as PET-tracers for measuring P-glycoprotein function: in vitro and in vivo evaluation. Luurtsema G, Molthoff CF, Windhorst AD, Smit JW, Keizer H, Boellaard R, Lammertsma AA, Franssen EJ. Nucl Med Biol; 2003 Oct 25; 30(7):747-51. PubMed ID: 14499333 [Abstract] [Full Text] [Related]
10. Drug-Drug Interactions of a Novel κ-Opioid Receptor Agonist, Nalfurafine Hydrochloride, Involving the P-Glycoprotein. Ando A, Sasago S, Ohzone Y, Miyamoto Y. Eur J Drug Metab Pharmacokinet; 2016 Oct 25; 41(5):549-58. PubMed ID: 26058994 [Abstract] [Full Text] [Related]
11. Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport. Katoh M, Nakajima M, Yamazaki H, Yokoi T. Eur J Pharm Sci; 2001 Feb 25; 12(4):505-13. PubMed ID: 11231118 [Abstract] [Full Text] [Related]
12. Interaction of digoxin with antihypertensive drugs via MDR1. Takara K, Kakumoto M, Tanigawara Y, Funakoshi J, Sakaeda T, Okumura K. Life Sci; 2002 Feb 15; 70(13):1491-500. PubMed ID: 11895100 [Abstract] [Full Text] [Related]
14. Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier. van der Sandt IC, Vos CM, Nabulsi L, Blom-Roosemalen MC, Voorwinden HH, de Boer AG, Breimer DD. AIDS; 2001 Mar 09; 15(4):483-91. PubMed ID: 11242145 [Abstract] [Full Text] [Related]
15. In Vitro P-Glycoprotein-Mediated Transport of Tadalafil: A Comparison with Sildenafil. Higashi H, Watanabe N, Tamura R, Taguchi M. Biol Pharm Bull; 2017 Mar 09; 40(8):1314-1319. PubMed ID: 28769012 [Abstract] [Full Text] [Related]
16. A transcellular assay to assess the P-gp inhibition in early stage of drug development. Taur JS, Schuck EL, Wong NY. Drug Metab Lett; 2012 Mar 09; 6(4):285-91. PubMed ID: 23879790 [Abstract] [Full Text] [Related]
18. Utility of P-glycoprotein and organic cation transporter 1 double-transfected LLC-PK1 cells for studying the interaction of YM155 monobromide, novel small-molecule survivin suppressant, with P-glycoprotein. Iwai M, Minematsu T, Li Q, Iwatsubo T, Usui T. Drug Metab Dispos; 2011 Dec 09; 39(12):2314-20. PubMed ID: 21918035 [Abstract] [Full Text] [Related]
19. Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein. Adachi Y, Suzuki H, Sugiyama Y. Pharm Res; 2001 Dec 09; 18(12):1660-8. PubMed ID: 11785684 [Abstract] [Full Text] [Related]
20. Kinetics of doxorubicin handling in the LLC-PK1 kidney epithelial cell line is mediated by both vesicle formation and P-glycoprotein drug transport. Crivellato E, Candussio L, Rosati AM, Decorti G, Klugmann FB, Mallardi F. Histochem J; 1999 Oct 09; 31(10):635-43. PubMed ID: 10576412 [Abstract] [Full Text] [Related] Page: [Next] [New Search]